1-3 of 3
Martin R. Berger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B105: Antineoplastic effects and expression modulations in proliferation/apoptosis related genes by riproximin in breast cancer cells

Asim Pervaiz, Asma Khan, Kiran Umer, Martin R. Berger
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B105.
https://doi.org/10.1158/1535-7163.TARG-23-B105
Published: 01 December 2023
View article titled, Abstract B105: Antineoplastic effects and expression modulations in proliferation/apoptosis related genes by riproximin in breast cancer cells
Journal Articles

Abstract A025: Cytostatic effects and expression modulations in cell cycle genes by a 3rd generation alkyl-phospholipid (erufosine) in liver and lung cancer cells

Asim Pervaiz, Marriyam Nasim, Nazakat Shafiq, Martin R. Berger
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): A025.
https://doi.org/10.1158/1535-7163.TARG-23-A025
Published: 01 December 2023
View article titled, Abstract A025: Cytostatic effects and expression modulations in cell cycle genes by a 3<sup>rd</sup> generation alkyl-phospholipid (erufosine) in liver and lung cancer cells
Journal Articles

Combination with an Antisense Oligonucleotide Synergistically Improves the Antileukemic Efficacy of Erucylphospho-N,N,N -trimethylpropylammonium in Chronic Myeloid Leukemia Cell Lines

Spiro M. Konstantinov, Milka C. Georgieva, Margarita Topashka-Ancheva, Hansjörg Eibl, Martin R. Berger
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (10): 877–884.
Published: 01 August 2002
View article titled, Combination with an Antisense Oligonucleotide Synergistically Improves the Antileukemic Efficacy of Erucylphospho-<em>N,N,N</em> -trimethylpropylammonium in Chronic Myeloid Leukemia Cell Lines
Open the PDF for Combination with an Antisense Oligonucleotide Synergistically Improves the Antileukemic Efficacy of Erucylphospho-<em>N,N,N</em> -trimethylpropylammonium in Chronic Myeloid Leukemia Cell Lines in another window